Annual Scottsdale event benefiting TGen returns October 9 with an inspiring morning dedicated to accelerating discoveries for women facing cancer
PHOENIX – May 27, 2026 – The Translational Genomics Research Institute (TGen), part of City of Hope, together with Neiman Marcus and Scottsdale Fashion Square, will host the sixth annual Runway for Research on Friday, October 9, from 9 to 11 a.m. at Scottsdale Fashion Square’s Luxury Wing.
Uniting Arizona’s philanthropic, fashion and business communities, Runway for Research is an inspiring morning dedicated to accelerating the future of women’s cancer research. Powered by philanthropy, innovation, and community partnership, this signature event supports research that can save lives.
“Philanthropy plays a critical role in helping research move faster,” said Meghan Frost, Vice President of Philanthropy, Arizona Market. “When our community invests in women’s cancer research, we give scientists the resources they need to explore new ideas, test promising approaches, and move discoveries from the lab to the people who need them most.”
Inspired by the spirit, strength and momentum of the Year of the Horse, this year’s event celebrates the determination to move research forward faster for women facing cancer. Guests are encouraged to wear shades of pink in honor of Breast Cancer Awareness Month as they gather to support groundbreaking discoveries in precision medicine, early detection, and more personalized cancer treatments.
The event will feature an exclusive runway fashion show, luxury shopping experiences, and opportunities to support transformative cancer research that has the potential to improve outcomes for women everywhere.
This year’s event is co-chaired by community advocates Lee Courtney and Justine Hurry, whose leadership and dedication continue to help expand awareness and support for women’s cancer research in Arizona.
“So many of us have been impacted by cancer in some way, which is why this event feels incredibly meaningful,” said Lee Courtney. “By supporting innovative cancer research, we’re helping ensure that women in Arizona have access to more personalized and effective care.”
For more than two decades, TGen has pioneered leading-edge research focused on translating scientific discoveries into more precise and effective treatments for patients facing cancer and other complex diseases. Through philanthropy and collaboration, events like Runway for Research help accelerate discoveries from the laboratory directly to patient care.
“As co‑chairs, Lee and I see first-hand how this event strengthens our community,” said Justine Hurry. “Runway for Research brings people together to discover what precision medicine can do and to champion research that directly supports women faced with a cancer diagnosis.”
Event ticket and sponsorship information is available at tgen.org/runway
# # #
About TGen, part of City of Hope
Translational Genomics Research Institute (TGen) is a Phoenix, Arizona-based nonprofit organization dedicated to conducting groundbreaking research with life-changing results. TGen is part of City of Hope, a world-renowned independent research and treatment center for cancer, diabetes and other life-threatening diseases. This precision medicine affiliation enables both institutes to complement each other in research and patient care, with City of Hope providing a significant clinical setting to advance scientific discoveries made by TGen. TGen is focused on helping patients with neurological disorders, cancer, diabetes and infectious diseases through cutting-edge translational research (the process of rapidly moving research toward patient benefit). TGen physicians and scientists work to unravel the genetic components of both common and complex rare diseases in adults and children. Working with collaborators in the scientific and medical communities worldwide, TGen makes a substantial contribution to help patients through efficiency and effectiveness of the translational process.
About City of Hope
City of Hope’s mission is to make hope a reality for all touched by cancer and diabetes. Founded in 1913, City of Hope has grown into one of the largest and most advanced cancer research and treatment organizations in the United States, and one of the leading research centers for diabetes and other life-threatening illnesses. City of Hope research has been the basis for numerous breakthrough cancer medicines, as well as human synthetic insulin and monoclonal antibodies. With an independent, National Cancer Institute-designated comprehensive cancer center that is ranked among the nation’s top cancer centers by U.S. News & World Report at its core, City of Hope’s uniquely integrated model spans cancer care, research and development, academics and training, and a broad philanthropy program that powers its work. City of Hope’s growing national system includes its Los Angeles campus, a network of clinical care locations across Southern California, a new cancer center in Orange County, California, and cancer treatment centers and outpatient facilities in the Atlanta, Chicago and Phoenix areas. City of Hope’s affiliated group of organizations includes Translational Genomics Research Institute and AccessHopeTM. For more information about City of Hope, follow us on Facebook, X, YouTube, Instagram and LinkedIn.
Media Contacts
TGen
Galen Perry
602-343-8423
gperry@tgen.org
May 27, 2026 | Media Release